NCT00043784View on ClinicalTrials.gov

SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes

PHASE3CompletedINTERVENTIONAL
Enrollment

8,000

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

February 28, 2005

Conditions
Unstable AnginaMyocardial InfarctionMyocardial Ischemia
Interventions
DRUG

enoxaparin

Trial Locations (1)

07969

Duke Clinical Research Institute, Durham

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY